Alprazolam

Product NDC: 65862-678
11-digit product format: 658620678
Labeler code: 65862
Product ID: 65862-678_7527aeb7-8912-404d-afb7-8c692c84422b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Alprazolam
Dosage form: TABLET
Route: ORAL
Labeler: Aurobindo Pharma Limited
Application: ANDA203346
Marketing category: ANDA
Marketing start: 2015-07-31
Substance: ALPRAZOLAM
Active strength: 1 mg/1
Pharmacologic classes: Benzodiazepine [EPC], Benzodiazepines [CS]
DEA schedule: CIV
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
unfinished product	product	65862-678		UNFINISHED	Active or certified unfinished drug listing		2026-10-12
unfinished package	package	65862-678	65862-678-49	UNFINISHED	Active or certified unfinished drug listing		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 21:27 UTC · source 2025-12-05	unfinished product	product		`a6255e0c9aa5…`	`a0211a219f2e…`
2025-12-14 21:27 UTC · source 2025-12-05	unfinished package	package	65862-678-49	`a6255e0c9aa5…`	`a0211a219f2e…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished product	product		`1d862106b807…`	`00c93037cd84…`
2025-08-26 23:59 UTC · source 2025-08-26	unfinished package	package	65862-678-49	`1d862106b807…`	`00c93037cd84…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished product	product		`390b4c401c3f…`	`2c692c2daee3…`
2025-05-15 14:59 UTC · source 2025-05-14	unfinished package	package	65862-678-49	`390b4c401c3f…`	`2c692c2daee3…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished product	product		`e30019b0c005…`	`a3f0b14938b7…`
2025-04-01 07:37 UTC · source 2025-03-31	unfinished package	package	65862-678-49	`e30019b0c005…`	`a3f0b14938b7…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished product	product		`bbbc9f937eca…`	`946b9c97cf81…`
2025-03-01 13:19 UTC · source 2025-02-28	unfinished package	package	65862-678-49	`bbbc9f937eca…`	`946b9c97cf81…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished product	product		`f268b84574a6…`	`26285f5ac5df…`
2025-02-27 05:24 UTC · source 2025-02-26	unfinished package	package	65862-678-49	`f268b84574a6…`	`26285f5ac5df…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished product	product		`f764e8902f78…`	`92046438deef…`
2025-02-01 13:13 UTC · source 2025-01-31	unfinished package	package	65862-678-49	`f764e8902f78…`	`92046438deef…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished product	product		`68b1e3bced9e…`	`98a755eb8bc6…`
2025-01-20 13:05 UTC · source 2025-01-17	unfinished package	package	65862-678-49	`68b1e3bced9e…`	`98a755eb8bc6…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished product	product		`05c55d027831…`	`ca05dca9dc4c…`
2024-11-29 20:42 UTC · source 2024-11-29	unfinished package	package	65862-678-49	`05c55d027831…`	`ca05dca9dc4c…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished product	product		`48b4f40e6753…`	`c7c7a00d2afa…`
2024-11-09 02:36 UTC · source 2024-11-08	unfinished package	package	65862-678-49	`48b4f40e6753…`	`c7c7a00d2afa…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished product	product		`27f29a85d7e4…`	`1372111e901f…`
2024-10-09 02:27 UTC · source 2024-10-08	unfinished package	package	65862-678-49	`27f29a85d7e4…`	`1372111e901f…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished product	product		`8d62ce987f31…`	`9fe9ef23e30d…`
2024-07-10 04:00 UTC · source 2024-07-09	unfinished package	package	65862-678-49	`8d62ce987f31…`	`9fe9ef23e30d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished product	product		`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-28 21:11 UTC · source 2024-05-28	unfinished package	package	65862-678-49	`d1e113ab4d42…`	`063ee3eb0a1d…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished product	product		`50b4072663b7…`	`eae3003ed65e…`
2024-05-15 03:51 UTC · source 2024-05-14	unfinished package	package	65862-678-49	`50b4072663b7…`	`eae3003ed65e…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished product	product		`906f6e251498…`	`bf70b80e44f0…`
2022-04-09 23:13 UTC · source 2022-04-08	unfinished package	package	65862-678-49	`906f6e251498…`	`bf70b80e44f0…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished product	product		`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished package	package	65862-678-49	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished product	product		`8fc7167e32ce…`	`e96bbc724034…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished package	package	65862-678-49	`8fc7167e32ce…`	`e96bbc724034…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished product	product		`4184dd79f89f…`	`545327b3e20f…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished package	package	65862-678-49	`4184dd79f89f…`	`545327b3e20f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished product	product		`4bd3596a7b87…`	`5c64c6f6865f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished package	package	65862-678-49	`4bd3596a7b87…`	`5c64c6f6865f…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished product	product		`263afe128892…`	`91768de4ddbe…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished package	package	65862-678-49	`263afe128892…`	`91768de4ddbe…`
2019-06-01 22:24 UTC · source 2019-05-30	unfinished product	product		`5b2001dcd8f5…`	`54b53d4dc9e4…`
2019-06-01 22:24 UTC · source 2019-05-30	unfinished package	package	65862-678-49	`5b2001dcd8f5…`	`54b53d4dc9e4…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A203346-001	ALPRAZOLAM	ALPRAZOLAM	0.25MG	TABLET / ORAL	AB	2015-07-31
A203346-002	ALPRAZOLAM	ALPRAZOLAM	0.5MG	TABLET / ORAL	AB	2015-07-31
A203346-003	ALPRAZOLAM	ALPRAZOLAM	1MG	TABLET / ORAL	AB	2015-07-31
A203346-004	ALPRAZOLAM	ALPRAZOLAM	2MG	TABLET / ORAL	AB	2015-07-31

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A203346-001	AB
A203346-002	AB
A203346-003	AB
A203346-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A203346-001	ALPRAZOLAM	0.25MG	TABLET / ORAL	AB	2015-07-31	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203346-002	ALPRAZOLAM	0.5MG	TABLET / ORAL	AB	2015-07-31	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203346-003	ALPRAZOLAM	1MG	TABLET / ORAL	AB	2015-07-31	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203346-004	ALPRAZOLAM	2MG	TABLET / ORAL	AB	2015-07-31	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A203346-001	ALPRAZOLAM	0.25MG	TABLET / ORAL	AB	2015-07-31	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203346-002	ALPRAZOLAM	0.5MG	TABLET / ORAL	AB	2015-07-31	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203346-003	ALPRAZOLAM	1MG	TABLET / ORAL	AB	2015-07-31	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203346-004	ALPRAZOLAM	2MG	TABLET / ORAL	AB	2015-07-31	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203346-001	ALPRAZOLAM	0.25MG	TABLET / ORAL	AB	2015-07-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203346-002	ALPRAZOLAM	0.5MG	TABLET / ORAL	AB	2015-07-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203346-003	ALPRAZOLAM	1MG	TABLET / ORAL	AB	2015-07-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203346-004	ALPRAZOLAM	2MG	TABLET / ORAL	AB	2015-07-31	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203346-001	ALPRAZOLAM	0.25MG	TABLET / ORAL	AB	2015-07-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203346-002	ALPRAZOLAM	0.5MG	TABLET / ORAL	AB	2015-07-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203346-003	ALPRAZOLAM	1MG	TABLET / ORAL	AB	2015-07-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203346-004	ALPRAZOLAM	2MG	TABLET / ORAL	AB	2015-07-31	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203346-001	ALPRAZOLAM	0.25MG	TABLET / ORAL	AB	2015-07-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203346-002	ALPRAZOLAM	0.5MG	TABLET / ORAL	AB	2015-07-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203346-003	ALPRAZOLAM	1MG	TABLET / ORAL	AB	2015-07-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203346-004	ALPRAZOLAM	2MG	TABLET / ORAL	AB	2015-07-31	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203346-001	ALPRAZOLAM	0.25MG	TABLET / ORAL	AB	2015-07-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203346-002	ALPRAZOLAM	0.5MG	TABLET / ORAL	AB	2015-07-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203346-003	ALPRAZOLAM	1MG	TABLET / ORAL	AB	2015-07-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203346-004	ALPRAZOLAM	2MG	TABLET / ORAL	AB	2015-07-31	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203346-001	ALPRAZOLAM	0.25MG	TABLET / ORAL	AB	2015-07-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203346-002	ALPRAZOLAM	0.5MG	TABLET / ORAL	AB	2015-07-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203346-003	ALPRAZOLAM	1MG	TABLET / ORAL	AB	2015-07-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203346-004	ALPRAZOLAM	2MG	TABLET / ORAL	AB	2015-07-31	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203346-001	ALPRAZOLAM	0.25MG	TABLET / ORAL	AB	2015-07-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203346-002	ALPRAZOLAM	0.5MG	TABLET / ORAL	AB	2015-07-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203346-003	ALPRAZOLAM	1MG	TABLET / ORAL	AB	2015-07-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203346-004	ALPRAZOLAM	2MG	TABLET / ORAL	AB	2015-07-31	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203346-001	ALPRAZOLAM	0.25MG	TABLET / ORAL	AB	2015-07-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203346-002	ALPRAZOLAM	0.5MG	TABLET / ORAL	AB	2015-07-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203346-003	ALPRAZOLAM	1MG	TABLET / ORAL	AB	2015-07-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203346-004	ALPRAZOLAM	2MG	TABLET / ORAL	AB	2015-07-31	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203346-001	ALPRAZOLAM	0.25MG	TABLET / ORAL	AB	2015-07-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203346-002	ALPRAZOLAM	0.5MG	TABLET / ORAL	AB	2015-07-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203346-003	ALPRAZOLAM	1MG	TABLET / ORAL	AB	2015-07-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203346-004	ALPRAZOLAM	2MG	TABLET / ORAL	AB	2015-07-31	`5bbf6a4d5a75…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A203346-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203346-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203346-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203346-004	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A203346-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203346-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203346-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203346-004	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203346-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203346-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203346-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203346-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203346-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203346-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203346-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203346-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203346-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203346-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203346-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203346-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203346-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203346-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203346-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203346-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203346-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203346-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203346-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203346-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203346-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203346-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203346-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203346-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203346-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203346-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203346-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203346-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203346-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203346-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203346-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203346-004	AB	1	`5bbf6a4d5a75…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Alprazolam
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ALPRAZOLAM	1 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
YU55MQ3IZY	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
197321	Internal RxNorm lookup
197322	Internal RxNorm lookup
308047	Internal RxNorm lookup
308048	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
d2fd0b3e-9b78-44d0-82a6-96d6c6238750	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
2ffbe5ef-58ff-88b9-e291-045e0f861f4f	Product name	4	20180827
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717
1f9e6d58-49d3-d9c1-e570-4bb0466a2c0b	Product name	1	20140508
a1a11520-f3e2-68fa-8bd9-e80b271ef797	Product name	1	20140508
d153678e-a3c8-bad8-cfe0-385656dde0e7	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
65862-678-01	Alprazolam	100 in 1 BOTTLE	TABLET	100	10
65862-678-05	Alprazolam	500 in 1 BOTTLE	TABLET	500	10
65862-678-99	Alprazolam	1000 in 1 BOTTLE	TABLET	1000	10

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
65862-678-01	EA - Each	65862-678	bedd2120-11c8-4290-ad8d-2d79575ba05f	1	2020-04-20
65862-678-05	EA - Each	65862-678	4f702eaf-2b6f-4ea0-a74e-dbab3ee8466b	1	2020-04-20
65862-678-99	EA - Each	65862-678	b50001f1-c230-4c50-a89a-a81c4a9228f4	1	2018-03-08

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ALPRAZOLAM	ACTIVE INGREDIENT	YU55MQ3IZY	ALPRAZOLAM TABLET [AUROBINDO PHARMA LIMITED]	1
ALPRAZOLAM	ACTIVE MOIETY	YU55MQ3IZY	ALPRAZOLAM TABLET [AUROBINDO PHARMA LIMITED]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ALPRAZOLAM TABLET [AUROBINDO PHARMA LIMITED]	1
DOCUSATE SODIUM	INACTIVE INGREDIENT	F05Q2T2JA0	ALPRAZOLAM TABLET [AUROBINDO PHARMA LIMITED]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	ALPRAZOLAM TABLET [AUROBINDO PHARMA LIMITED]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	ALPRAZOLAM TABLET [AUROBINDO PHARMA LIMITED]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ALPRAZOLAM TABLET [AUROBINDO PHARMA LIMITED]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ALPRAZOLAM TABLET [AUROBINDO PHARMA LIMITED]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ALPRAZOLAM TABLET [AUROBINDO PHARMA LIMITED]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	ALPRAZOLAM TABLET [AUROBINDO PHARMA LIMITED]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ALPRAZOLAM TABLET [AUROBINDO PHARMA LIMITED]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
65862-678	ALPRAZOLAM TABLET [AUROBINDO PHARMA LIMITED]	8	Current NDC, Legacy NDC, 3 package rows	20230310_d2fd0b3e-9b78-44d0-82a6-96d6c6238750.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 29 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Alprazolam	ALPRAZOLAM	NuCare Pharmaceuticals, Inc.	315b8cf2-01a0-3f7d-e063-6394a90a39b5	2025-03-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203346 application number: ANDA203346
Alprazolam	ALPRAZOLAM	Direct_Rx	f77cfdd0-847d-4edd-e053-6394a90a91b7	2025-01-22	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203346 application number: ANDA203346
Alprazolam	ALPRAZOLAM	NuCare Pharmaceuticals,Inc.	02840ea6-e4a0-96a0-e063-6394a90a19ae	2025-01-03	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203346 application number: ANDA203346
Alprazolam	ALPRAZOLAM	American Health Packaging	ea95d182-453b-4c43-8402-d65c488d55f2	2024-12-30	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203346 application number: ANDA203346
Alprazolam	ALPRAZOLAM	Advanced Rx of Tennessee, LLC	26f8b63c-6dad-8fac-e063-6394a90a5435	2024-11-06	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203346 application number: ANDA203346
Alprazolam	ALPRAZOLAM	NuCare Pharmaceuticals,Inc.	f7e63d96-2310-4ab1-e053-6294a90a86fc	2024-09-03	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203346 application number: ANDA203346
Alprazolam	ALPRAZOLAM	Medsource Pharmaceuticals	14960c0c-555f-acc1-e063-6394a90a232a	2024-03-26	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203346 application number: ANDA203346
Alprazolam	ALPRAZOLAM	NuCare Pharmaceuticals,Inc.	f9903822-642d-e364-e053-6394a90a22d8	2024-03-12	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203346 application number: ANDA203346
Alprazolam	ALPRAZOLAM	Proficient Rx LP	68e6ef8c-4104-4636-9719-6aa386c892d9	2023-10-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203346 application number: ANDA203346

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
YU55MQ3IZY	ALPRAZOLAM	28981-97-7	ALPRAZOLAM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197321	ALPRAZolam 1 MG Oral Tablet	PSN	d8364af1-d23e-4cd7-9a81-077ae97a951a	103
197321	alprazolam 1 MG Oral Tablet	SCD	d8364af1-d23e-4cd7-9a81-077ae97a951a	103
308047	ALPRAZolam 0.25 MG Oral Tablet	PSN	d2fd0b3e-9b78-44d0-82a6-96d6c6238750	10
308048	ALPRAZolam 0.5 MG Oral Tablet	PSN	d2fd0b3e-9b78-44d0-82a6-96d6c6238750	10
197321	ALPRAZolam 1 MG Oral Tablet	PSN	d2fd0b3e-9b78-44d0-82a6-96d6c6238750	10
197322	ALPRAZolam 2 MG Oral Tablet	PSN	d2fd0b3e-9b78-44d0-82a6-96d6c6238750	10
308047	alprazolam 0.25 MG Oral Tablet	SCD	d2fd0b3e-9b78-44d0-82a6-96d6c6238750	10
308048	alprazolam 0.5 MG Oral Tablet	SCD	d2fd0b3e-9b78-44d0-82a6-96d6c6238750	10
197321	alprazolam 1 MG Oral Tablet	SCD	d2fd0b3e-9b78-44d0-82a6-96d6c6238750	10
197322	alprazolam 2 MG Oral Tablet	SCD	d2fd0b3e-9b78-44d0-82a6-96d6c6238750	10
197321	ALPRAZolam 1 MG Oral Tablet	PSN	f6dd8005-1d50-41bc-e053-6394a90ac45b	5
197321	alprazolam 1 MG Oral Tablet	SCD	f6dd8005-1d50-41bc-e053-6394a90ac45b	5
197321	ALPRAZolam 1 MG Oral Tablet	PSN	f7e63d96-2310-4ab1-e053-6294a90a86fc	4
197321	ALPRAZolam 1 MG Oral Tablet	PSN	dc130aae-4510-4de7-a750-4a144e88208d	4
197321	alprazolam 1 MG Oral Tablet	SCD	f7e63d96-2310-4ab1-e053-6294a90a86fc	4
197321	alprazolam 1 MG Oral Tablet	SCD	dc130aae-4510-4de7-a750-4a144e88208d	4
308047	ALPRAZolam 0.25 MG Oral Tablet	PSN	8d76a554-7ed1-4c93-a5ea-30898aec0aa1	1
308047	ALPRAZolam 0.25 MG Oral Tablet	PSN	3fa14fa4-45a7-6ef4-e063-6394a90a1dcd	1
308048	ALPRAZolam 0.5 MG Oral Tablet	PSN	8d76a554-7ed1-4c93-a5ea-30898aec0aa1	1
308048	ALPRAZolam 0.5 MG Oral Tablet	PSN	3fa14fa4-45a7-6ef4-e063-6394a90a1dcd	1
197321	ALPRAZolam 1 MG Oral Tablet	PSN	8d76a554-7ed1-4c93-a5ea-30898aec0aa1	1
197321	ALPRAZolam 1 MG Oral Tablet	PSN	5111e57d-8920-6861-e063-6294a90a2194	1
197321	ALPRAZolam 1 MG Oral Tablet	PSN	3fa14fa4-45a7-6ef4-e063-6394a90a1dcd	1
197321	ALPRAZolam 1 MG Oral Tablet	PSN	fc5fe795-6b41-aecf-e053-6394a90af562	1
197321	ALPRAZolam 1 MG Oral Tablet	PSN	26f8b63c-6dad-8fac-e063-6394a90a5435	1
197322	ALPRAZolam 2 MG Oral Tablet	PSN	8d76a554-7ed1-4c93-a5ea-30898aec0aa1	1
308047	alprazolam 0.25 MG Oral Tablet	SCD	8d76a554-7ed1-4c93-a5ea-30898aec0aa1	1
308047	alprazolam 0.25 MG Oral Tablet	SCD	3fa14fa4-45a7-6ef4-e063-6394a90a1dcd	1
308048	alprazolam 0.5 MG Oral Tablet	SCD	8d76a554-7ed1-4c93-a5ea-30898aec0aa1	1
308048	alprazolam 0.5 MG Oral Tablet	SCD	3fa14fa4-45a7-6ef4-e063-6394a90a1dcd	1
197321	alprazolam 1 MG Oral Tablet	SCD	fc5fe795-6b41-aecf-e053-6394a90af562	1
197321	alprazolam 1 MG Oral Tablet	SCD	8d76a554-7ed1-4c93-a5ea-30898aec0aa1	1
197321	alprazolam 1 MG Oral Tablet	SCD	5111e57d-8920-6861-e063-6294a90a2194	1
197321	alprazolam 1 MG Oral Tablet	SCD	3fa14fa4-45a7-6ef4-e063-6394a90a1dcd	1
197321	alprazolam 1 MG Oral Tablet	SCD	26f8b63c-6dad-8fac-e063-6394a90a5435	1
197322	alprazolam 2 MG Oral Tablet	SCD	8d76a554-7ed1-4c93-a5ea-30898aec0aa1	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
65862-678-01	65862067801	100 TABLET in 1 BOTTLE (65862-678-01)	100 tablet	2015-07-31	0000-00-00	No	No	Current
65862-678-05	65862067805	500 TABLET in 1 BOTTLE (65862-678-05)	500 tablet	2015-07-31	0000-00-00	No	No	Current
65862-678-49	65862067849	4000 TABLET in 1 BAG (65862-678-49)	4000 tablet	31-JUL-15				Current
65862-678-99	65862067899	1000 TABLET in 1 BOTTLE (65862-678-99)	1000 tablet	2015-07-31	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Alprazolam	Clinical Solutions Wholesale, LLC	2026-07-28	HUMAN PRESCRIPTION DRUG LABEL	1
Alprazolam	St. Mary's Medical Park Pharmacy	2026-06-02	HUMAN PRESCRIPTION DRUG LABEL	2
Alprazolam	Coupler LLC	2026-05-05	HUMAN PRESCRIPTION DRUG LABEL	1
Alprazolam	ASCLEMED USA INC. \| ASCLEMED USA INC. DBA ENOVACHEM	2026-04-30	HUMAN PRESCRIPTION DRUG LABEL	1
Alprazolam	Bryant Ranch Prepack	2026-04-13	HUMAN PRESCRIPTION DRUG LABEL	103
Alprazolam C-IV	Direct_Rx	2026-03-05	HUMAN PRESCRIPTION DRUG LABEL	5
Alprazolam	PreferredPharmaceuticals Inc. \| Preferred Pharmaceuticals Inc.	2026-02-20	HUMAN PRESCRIPTION DRUG LABEL	4
Alprazolam	Aurobindo Pharma Limited	2025-12-11	Human Prescription Drug Label	10
Alprazolam	AvPAK	2025-09-25	HUMAN PRESCRIPTION DRUG LABEL	1
Alprazolam	Advanced Rx of Tennessee, LLC	2024-11-06	HUMAN PRESCRIPTION DRUG LABEL	1
Alprazolam	NuCare Pharmaceuticals,Inc.	2024-09-03	HUMAN PRESCRIPTION DRUG LABEL	4
Alprazolam	REMEDYREPACK INC.	2024-03-28	HUMAN PRESCRIPTION DRUG LABEL	2
Alprazolam Tablets, USP CIV	NCS HealthCare of KY, LLC dba Vangard Labs	2022-07-28	HUMAN PRESCRIPTION DRUG LABEL	7